Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
10.25Prev. Close
10.27Volume
12,026Total traded value
0.01 CrUpper Circuit
12.32Lower Circuit
8.22Fundamentals
| Market Cap | ₹10Cr |
| ROE | -22.23% |
| P/E Ratio(TTM) | -1.10 |
| EPS(TTM) | -9.36 |
| P/B Ratio | 0.45 |
| Dividend Yield | 0.00% |
| Industry P/E | 35.77 |
| Book Value | 22.63 |
| Debt to Equity | 0.01 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Decipher Labs
Decipher Labs is a pharmaceutical company that trades and manufactures drugs, while also offering consultancy services and expanding its global presence through subsidiaries. The company pushes itself to re-innovate and decipher the future by building on its core strengths to explore new markets and opportunities. On a standalone basis, it achieved a net profit of ₹2.33 Lakhs, a strong turnaround from the previous year's loss.;
| Parent Organisation | Decipher Labs Limited |
| BSE Symbol | 524752 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 103.18 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.33 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.60 | ||
| Wockhardt | NA (0.00%) | -195.86 |